Tissue factor over-expression by human pancreatic cancer cells BXPC3 is related to higher prothrombotic potential as compared to breast cancer cells MCF7-Reference-Cited by-同舟云学术

Tissue factor over-expression by human pancreatic cancer cells BXPC3 is related to higher prothrombotic potential as compared to breast cancer cells MCF7

Published:2012-06 Issue:6 Volume:129 Page:779-786
ISSN:0049-3848
Container-title:Thrombosis Research
language:en
Short-container-title:Thrombosis Research

Author:

Gerotziafas Grigoris T.,Galea Vassiliki,Mbemba Elisabeth,Khaterchi Amir,Sassi Mouna,Baccouche Hela,Prengel Claudie,van Dreden Patrick,Hatmi Mohamed,Bernaudin Jean François,Elalamy Ismail

Publisher

Elsevier BV

Subject

Hematology

Reference46 articles.

1. Phlegmasia alba dolens;Trousseau,1865

2. Predictors of recurrence after deep vein thrombosis and pulmonary embolism;Heit;Arch Intern Med,2000

3. Malignancies, prothrombotic mutations, and the risk of venous thrombosis;Blom;JAMA,2005

4. Venous thromboembolism (VTE) in patients with cancer: epidemiology and risk factors;Wun;Cancer Invest,2009

5. Cancer-associated thrombosis;Zwicker;Crit Rev Oncol Hematol,2007

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The procoagulant signature of cancer cells drives fibrin network formation in tumor microenvironment and impacts its quality. Implications in cancer cell migration and the resistance to anticancer agents;Thrombosis Research;2024-06

2. Differentiating benign and malignant neoplasms: A possible new role for coagulation and fibrinolysis indicators;2024-01-10

3. Differentiating benign and malignant neoplasms: A new role for coagulation and fibrinolysis indicators;2023-10-19

4. Small cell lung cancer: circulating tumor cell lines and expression of mediators of angiogenesis and coagulation;Exploration of Targeted Anti-tumor Therapy;2023-04-28

5. Treatment Resistance Risk in Patients with Newly Diagnosed Multiple Myeloma Is Associated with Blood Hypercoagulability: The ROADMAP-MM Study;Hemato;2022-02-22